Skynet USA Corporation | 702.969.5599 | Email: johnnyhong1962@gmail.com
WELCOME TO SKYNET USA NON PROFIT ORGANIZATION
STEM CELL DIVISION
Contact Mr. Johnny Hong - 洪 春 成
Tel No. 702.969.5599 for faster response
SOMEDAY... STEM CELL THERAPY WILL BE THE FIRST OPTION FOR WELLNESS!
Now available in the United States, Stem Cell Therapy is a non-Surgical Breakthrough Option of People Searching for Wellness Alternatives. Over 20,000 Stem Cell Therapies have been Conducted without Adverse Reactions.
HUMAN TISSUE QUALITIES
Our Stem Cell product is a proprietary morselized allograft flowable derived from amniotic tissue, donated by mothers delivering healthy babies by Caesarian section. Our amniotic allograft products deliver industry-leading quality in a variety of form factors. The amniotic connective tissue matrix includes elements such as growth factors, collagen scaffold, lipids, proteins, carbohydrates and other nutrients. These elements can serve to help protect, cushion, lubricate and reduce inflammation biologic structure of amniotic tissue in our stem cell product and make it an ideal choice for homologous clinical use. The proprietary extraction process maximizes the stem cell count and viability per unit.
READY TO USE:
Delivered as a ready to use flowable graft for precise delivery to the treatment site.
CRYOPRESERVED:
Cryopreservation proprietary process maximizes viability and the flowable’s concentration.
IMMUNOGENIC:
Placental tissues cause little to no immune response in the receiving patient
which otherwise may induce graft failure or fibrosia.
MIXABLE:
Intended for homologous use to supplement or replace damaged or suboptimal connective tissue.
QUALITY:
Procured through our proprietary process to preserve biological purity and to remove any antigens.
SAFE & COMPLIANT:
Our products go through comprehensive clinical testing to ensure they are safe and effective for patient use. We also comply with standards established by the American Association of Tissue Banks (AATB) and the HCT/P regulations established by the FDA. Our labs are also CLIA compliant and we meet industry specific requirements for maintaining Good Laboratory Practices (GLP).
Utah Cord Bank is a company with over 12 years of experience processing perinatal birth tissue products into therapeutic agents. It was founded by two PhDs with decades of combined experience and its founding philosophy was to bring innovation and value to stem cell based medicine. For 12 years, the company has been an industry leader and innovator, with a list of industry firsts, and has an impeccable safety record and exceptional treatment benefit track record. UCB has continued to grow and develop, while helping to push stem cell technology forward.
UCB is registered with the FDA and maintains compliance with Human Cells, Tissues, Cellular and Tissue-Based Product (HCT/P) regulations. The company prides itself on its state-of-the-art technology and its ability to provide products of the highest standards in the industry.
SPORTS SOLUTION
Cell Therapy USA offers new, cutting-edge treatment options like amniotic membrane stem cell injections that may be used to successfully treat patients with various musculoskeletal conditions.
CHILDREN’S AID
Cell Therapy USA can correct defects in children with inherited or inborn errors of metabolism by replacing these defective cells in the bone marrow with new, non-defective cells.
BABY BOOMER KEY
Baby Boomers are finding Cell Therapy USA provide nutrition and support directly to the human cell for its Anti-Aging Results. These are Nutraceutical Supplements, which means they are consumed rather than being applied as topical.
THE STEM CELL PROCEDURE
Involves non-surgical administer of healthy baby born umbilical cord blood live stem cells with or without additional injection into the injured area/joint. This simple procedure avoids the complicated and potentially dangerous nature of surgical procedures, but can also be used in conjunction with surgery to significantly reduce inflammation and speed the healing process.
THE CELL REGENERATIVE THERAPY IS A 20 MINUTE, NON-SURGICAL OPTION FOR PEOPLE SUFFERING FROM A
MULTITUDE OF CONDITIONS. TREATING SPORTS INJURIES WITH STEM CELL THERAPY, A PROCEDURE NORMALLY RESERVED FOR TOP ATHLETES, IS BECOMING MORE MAINSTREAM.
Denver Broncos quarterback Peyton Manning reportedly traveled to Europe a few years ago for stem-cell therapy to treat a neck injury when he was with the Colts, according to news reports. (Manning has not publicly acknowledged this). Hundreds of NFL players have used stem-cell therapy, which the NFL views as a medical treatment, not a steroid issue, according to a report in Sports Illustrated. The magazine noted how running back Chris Johnson had injured his knee and used stem cells to rebuild the cartilage.
Stem cells are the body’s main cells for repairing damaged tissue and reducing inflammation. They can divide and replenish cells damaged by disease, injury or normal wear.
HEMATOPOIETIC STEM CELLS CAN BE FOUND IN BONE MARROW (THE SPONGY TISSUE INSIDE BONES), THE BLOODSTREAM, AND THE UMBILICAL CORD BLOOD OF NEWBORN BABIES.
A stem cell transplant (sometimes called a bone marrow transplant) can replenish a child’s supply of healthy hematopoietic stem cells after they have been depleted. It’s used to treat a wide range of diseases, including cancers like leukemia, lymphoma, neuroblastoma, Wilms tumor, and certain testicular or ovarian cancers; blood disorders; immune system diseases; and bone marrow syndromes.
Children’s scientists and clinicians now hope to repeat these successes in other diseases, ranging from cystic fibrosis to neurologic disorders such as Fragile X syndrome, which has already modeled in pluripotent stem cells. In 2008, Children’s became the first center to establish a line of iPS cells from patients with specific diseases. There are now dozens of diseases modeled in iPS cells, raising hopes that better understanding of these conditions’ origins will soon lead to new treatment approaches.
MOST DEVELOPED COUNTRIES ARE FACING AN AGING POPULATION.
Currently, persons over 65 years of age represent 13 % of the American population, and this number is expected to grow as the “Baby Boomer” generation continues to age beyond 65. By 2030, they are projected to represent 16.9 % of the population; this segment will increase to 25.8 % by 2060. The changing demographics of the world’s population have wide-ranging implications that include a shift in medical needs. Given the above, there appears to be a deficiency in our understanding of the interactions in bone healing, especially in the elderly population. Specifically, aging may alter these interactions and thereby play an important role in the elderly patient’s ability for regeneration of musculoskeletal tissues. This will address the effect of aging in bone healing.
Now available in the United States, Stem Cell Therapy is a non-Surgical Breakthrough Option of People Searching for Wellness Alternatives. Over 20,000 Stem Cell Therapies have been Conducted without Adverse Reactions.
HUMAN TISSUE QUALITIES
Our Stem Cell product is a proprietary morselized allograft flowable derived from amniotic tissue, donated by mothers delivering healthy babies by Caesarian section. Our amniotic allograft products deliver industry-leading quality in a variety of form factors. The amniotic connective tissue matrix includes elements such as growth factors, collagen scaffold, lipids, proteins, carbohydrates and other nutrients. These elements can serve to help protect, cushion, lubricate and reduce inflammation biologic structure of amniotic tissue in our stem cell product and make it an ideal choice for homologous clinical use. The proprietary extraction process maximizes the stem cell count and viability per unit.
READY TO USE:
Delivered as a ready to use flowable graft for precise delivery to the treatment site.
CRYOPRESERVED:
Cryopreservation proprietary process maximizes viability and the flowable’s concentration.
IMMUNOGENIC:
Placental tissues cause little to no immune response in the receiving patient
which otherwise may induce graft failure or fibrosia.
MIXABLE:
Intended for homologous use to supplement or replace damaged or suboptimal connective tissue.
QUALITY:
Procured through our proprietary process to preserve biological purity and to remove any antigens.
SAFE & COMPLIANT:
Our products go through comprehensive clinical testing to ensure they are safe and effective for patient use. We also comply with standards established by the American Association of Tissue Banks (AATB) and the HCT/P regulations established by the FDA. Our labs are also CLIA compliant and we meet industry specific requirements for maintaining Good Laboratory Practices (GLP).
Utah Cord Bank is a company with over 12 years of experience processing perinatal birth tissue products into therapeutic agents. It was founded by two PhDs with decades of combined experience and its founding philosophy was to bring innovation and value to stem cell based medicine. For 12 years, the company has been an industry leader and innovator, with a list of industry firsts, and has an impeccable safety record and exceptional treatment benefit track record. UCB has continued to grow and develop, while helping to push stem cell technology forward.
UCB is registered with the FDA and maintains compliance with Human Cells, Tissues, Cellular and Tissue-Based Product (HCT/P) regulations. The company prides itself on its state-of-the-art technology and its ability to provide products of the highest standards in the industry.
SPORTS SOLUTION
Cell Therapy USA offers new, cutting-edge treatment options like amniotic membrane stem cell injections that may be used to successfully treat patients with various musculoskeletal conditions.
CHILDREN’S AID
Cell Therapy USA can correct defects in children with inherited or inborn errors of metabolism by replacing these defective cells in the bone marrow with new, non-defective cells.
BABY BOOMER KEY
Baby Boomers are finding Cell Therapy USA provide nutrition and support directly to the human cell for its Anti-Aging Results. These are Nutraceutical Supplements, which means they are consumed rather than being applied as topical.
THE STEM CELL PROCEDURE
Involves non-surgical administer of healthy baby born umbilical cord blood live stem cells with or without additional injection into the injured area/joint. This simple procedure avoids the complicated and potentially dangerous nature of surgical procedures, but can also be used in conjunction with surgery to significantly reduce inflammation and speed the healing process.
THE CELL REGENERATIVE THERAPY IS A 20 MINUTE, NON-SURGICAL OPTION FOR PEOPLE SUFFERING FROM A
MULTITUDE OF CONDITIONS. TREATING SPORTS INJURIES WITH STEM CELL THERAPY, A PROCEDURE NORMALLY RESERVED FOR TOP ATHLETES, IS BECOMING MORE MAINSTREAM.
Denver Broncos quarterback Peyton Manning reportedly traveled to Europe a few years ago for stem-cell therapy to treat a neck injury when he was with the Colts, according to news reports. (Manning has not publicly acknowledged this). Hundreds of NFL players have used stem-cell therapy, which the NFL views as a medical treatment, not a steroid issue, according to a report in Sports Illustrated. The magazine noted how running back Chris Johnson had injured his knee and used stem cells to rebuild the cartilage.
Stem cells are the body’s main cells for repairing damaged tissue and reducing inflammation. They can divide and replenish cells damaged by disease, injury or normal wear.
HEMATOPOIETIC STEM CELLS CAN BE FOUND IN BONE MARROW (THE SPONGY TISSUE INSIDE BONES), THE BLOODSTREAM, AND THE UMBILICAL CORD BLOOD OF NEWBORN BABIES.
A stem cell transplant (sometimes called a bone marrow transplant) can replenish a child’s supply of healthy hematopoietic stem cells after they have been depleted. It’s used to treat a wide range of diseases, including cancers like leukemia, lymphoma, neuroblastoma, Wilms tumor, and certain testicular or ovarian cancers; blood disorders; immune system diseases; and bone marrow syndromes.
Children’s scientists and clinicians now hope to repeat these successes in other diseases, ranging from cystic fibrosis to neurologic disorders such as Fragile X syndrome, which has already modeled in pluripotent stem cells. In 2008, Children’s became the first center to establish a line of iPS cells from patients with specific diseases. There are now dozens of diseases modeled in iPS cells, raising hopes that better understanding of these conditions’ origins will soon lead to new treatment approaches.
MOST DEVELOPED COUNTRIES ARE FACING AN AGING POPULATION.
Currently, persons over 65 years of age represent 13 % of the American population, and this number is expected to grow as the “Baby Boomer” generation continues to age beyond 65. By 2030, they are projected to represent 16.9 % of the population; this segment will increase to 25.8 % by 2060. The changing demographics of the world’s population have wide-ranging implications that include a shift in medical needs. Given the above, there appears to be a deficiency in our understanding of the interactions in bone healing, especially in the elderly population. Specifically, aging may alter these interactions and thereby play an important role in the elderly patient’s ability for regeneration of musculoskeletal tissues. This will address the effect of aging in bone healing.
Made in the USA- Umbilical Cord Blood - Baby Stem Cell (干细胞)
Please view VIDEO below for more details
English, Chinese 中文 and Korean
Please view VIDEO below for more details
English, Chinese 中文 and Korean
IMPORTANT:
THE COMPANY IS NOT OFFERING STEM CELL THERAPY AS A DIAGNOSIS, TREATMENT, CURE, OR PREVENTION FOR ANY CONDITION, DISEASE, OR INJURY. FDA COMPLIANCE PERTAIN TO THE PROCESS OF SOURCING STEM CELLS AND NOT THE APPROVAL STATUS, SAFETY RISKS, OR EFFECTIVENESS OF THE PRODUCT AND/OR PROCEDURE. THIS MATERIAL CONTAINS NO MEDICAL ADVICE. ALL STATEMENTS AND OPINIONS PROVIDED IN THIS MATERIAL, ANY MEDIA AND/OR WEBSITE ARE PROVIDED FOR EDUCATIONAL AND RESEARCH PURPOSES ONLY. OUR COMPANY IS OFFERING PATIENT-FUNDED RESEARCH TO PROVIDE STEM CELLS, PLATELET RICH PLASMA (“PRP” – INCLUDING THE INHERENT GROWTH FACTORS), AMNIOTIC CONNECTIVE TISSUE MATRIX AND/OR ALLOGENEOUS TISSUES AND ARE NOT INVOLVED IN THE USE OR MANUFACTURE BY ANY INVESTIGATIONAL DRUGS. ALTHOUGH THE PRODUCTS AND/OR PROCEDURES PRESENTED IN THIS MATERIAL HAVE WORKED FOR OTHERS, NO ONE CAN GUARANTEE SIMILAR RESULTS FOR ANYONE WHO VOLUNTARILY PARTICIPATES. RESULTS VARY DEPENDING ON ANY CIRCUMSTANCE. PATIENTS ARE URGED TO RESEARCH FURTHER, OR DISCUSS QUESTIONS WITH A QUALIFIED PROFESSIONAL ABOUT THE USE OF STEM CELLS OR RELATED PRODUCTS. ALL REPRESENTATIONS ARE VOID WHEREVER UTILIZATION OF COMPANY’S PRODUCTS AND/OR PROCEDURE IS PROHIBITED. PACKAGE BEING DELIVERED TO A PARTICIPATING INDIVIDUAL CONTAINS FDA COMPLIANT HUMAN CELLULAR AND TISSUE-BASED PRODUCTS (HCT/P) AS DEFINED IN US FDA 21 CFR Part 1271.
THE COMPANY IS NOT OFFERING STEM CELL THERAPY AS A DIAGNOSIS, TREATMENT, CURE, OR PREVENTION FOR ANY CONDITION, DISEASE, OR INJURY. FDA COMPLIANCE PERTAIN TO THE PROCESS OF SOURCING STEM CELLS AND NOT THE APPROVAL STATUS, SAFETY RISKS, OR EFFECTIVENESS OF THE PRODUCT AND/OR PROCEDURE. THIS MATERIAL CONTAINS NO MEDICAL ADVICE. ALL STATEMENTS AND OPINIONS PROVIDED IN THIS MATERIAL, ANY MEDIA AND/OR WEBSITE ARE PROVIDED FOR EDUCATIONAL AND RESEARCH PURPOSES ONLY. OUR COMPANY IS OFFERING PATIENT-FUNDED RESEARCH TO PROVIDE STEM CELLS, PLATELET RICH PLASMA (“PRP” – INCLUDING THE INHERENT GROWTH FACTORS), AMNIOTIC CONNECTIVE TISSUE MATRIX AND/OR ALLOGENEOUS TISSUES AND ARE NOT INVOLVED IN THE USE OR MANUFACTURE BY ANY INVESTIGATIONAL DRUGS. ALTHOUGH THE PRODUCTS AND/OR PROCEDURES PRESENTED IN THIS MATERIAL HAVE WORKED FOR OTHERS, NO ONE CAN GUARANTEE SIMILAR RESULTS FOR ANYONE WHO VOLUNTARILY PARTICIPATES. RESULTS VARY DEPENDING ON ANY CIRCUMSTANCE. PATIENTS ARE URGED TO RESEARCH FURTHER, OR DISCUSS QUESTIONS WITH A QUALIFIED PROFESSIONAL ABOUT THE USE OF STEM CELLS OR RELATED PRODUCTS. ALL REPRESENTATIONS ARE VOID WHEREVER UTILIZATION OF COMPANY’S PRODUCTS AND/OR PROCEDURE IS PROHIBITED. PACKAGE BEING DELIVERED TO A PARTICIPATING INDIVIDUAL CONTAINS FDA COMPLIANT HUMAN CELLULAR AND TISSUE-BASED PRODUCTS (HCT/P) AS DEFINED IN US FDA 21 CFR Part 1271.
Result From Stem Cell Therapy This breakthrough stem cell therapy procedure is a non-surgical treatment option for people suffering from a multitude of conditions.
*Heart Disease
*Lung Disease
*Autoimmune Disorders
*Diabetes Type ll
*Rheumatoid Arthritis
*Parkinson’s Disease
*Osteoarthritis
*Alzheimer’s Disease
*Chronic Joint Pain
*Lower Back Pain
*Multip Sclerosis
*Bulging or Herniated Discs
*Stroke
*Spinal Cord Injuries
*Dermatological Conditions
*Reduces Post-Operative
*Peyronie’s Disease
*Athletic Injuries
*Erectile Dysfuntion
*Meniscus,ACL or MCL Tears
*ALS (Lou Gehrig's Disease)
*Inflammation
*Heart Disease
*Lung Disease
*Autoimmune Disorders
*Diabetes Type ll
*Rheumatoid Arthritis
*Parkinson’s Disease
*Osteoarthritis
*Alzheimer’s Disease
*Chronic Joint Pain
*Lower Back Pain
*Multip Sclerosis
*Bulging or Herniated Discs
*Stroke
*Spinal Cord Injuries
*Dermatological Conditions
*Reduces Post-Operative
*Peyronie’s Disease
*Athletic Injuries
*Erectile Dysfuntion
*Meniscus,ACL or MCL Tears
*ALS (Lou Gehrig's Disease)
*Inflammation
干细胞治疗的结果
这种突破性干细胞治疗程序是对患
有多种病症的人的非手术治疗选择。
心脏病
肺部疾病
自身免疫性疾病
糖尿病ll型
类风湿关节炎
帕金森病
骨关节炎
老年痴呆症疾病
慢性关节疼痛
下背痛
多发性硬化
凸出或突出的椎间盘
行程
脊髓损伤
皮肤病
减少术后炎症
佩罗尼病
运动损伤
勃起功能障碍
这种突破性干细胞治疗程序是对患
有多种病症的人的非手术治疗选择。
心脏病
肺部疾病
自身免疫性疾病
糖尿病ll型
类风湿关节炎
帕金森病
骨关节炎
老年痴呆症疾病
慢性关节疼痛
下背痛
多发性硬化
凸出或突出的椎间盘
行程
脊髓损伤
皮肤病
减少术后炎症
佩罗尼病
运动损伤
勃起功能障碍
糖尿病ll型
Diabetes
Diabetes
勃起功能障碍
Erectile Dysfuntion
Erectile Dysfuntion
COST AMOUNT
$4,000
$7,280
$4,000
$7,280
ITEM NUMBER
1.00 CC
2.00 CC
1.00 CC
2.00 CC
SAVE 15%
$600
$1,092
$600
$1,092
COST 85%
$3,400
$6,188
$3,400
$6,188
For Doctors, Join Our Group of Stem Cell Providers!
• Offer a Drug-Free Therapy
• Increase Patient Database
• Increase Your Revenue Stream
• NO Huge Capital Investments Necessary
• Opportunity to Offer Other Existing Services
• Promote Your Clinic / Practice in Your Local Community
• Utilize High Quality Stem Cells from
FDA Compliant Facility.
• Offer a Drug-Free Therapy
• Increase Patient Database
• Increase Your Revenue Stream
• NO Huge Capital Investments Necessary
• Opportunity to Offer Other Existing Services
• Promote Your Clinic / Practice in Your Local Community
• Utilize High Quality Stem Cells from
FDA Compliant Facility.
For Individuals, We Are Ready to Help You!
• NO Surgery
• NO Need to Leave the Country
• NO Adverse Reactions
• Quick Procedure – Less than An Hour
• Very Affordable
• Monthly Payment Plans Available
• FICO SCORE 680 + Requirements
• NO Finance Charges
• Made in the USA
• NO Surgery
• NO Need to Leave the Country
• NO Adverse Reactions
• Quick Procedure – Less than An Hour
• Very Affordable
• Monthly Payment Plans Available
• FICO SCORE 680 + Requirements
• NO Finance Charges
• Made in the USA
Before and After
CERTIFIED STEM CELL THERAPY TREATMENTS CLINIC FACILITIES
心脏病
Heart Disease
Heart Disease
VIDEO No. 1
7:11 Minutes
7:11 Minutes
VIDEO No. 3
2:45 Minutes
2:45 Minutes
VIDEO No. 4
7:35 Minutes
7:35 Minutes
VIDEO No. 2
2:26 Minutes
2:26 Minutes
勃起功能障碍 Erectile Dysfuntion
Your baby’s cord blood may hold the key to their long-term health
Umbilical cord blood contains special stem cells that may unlock the promise of regenerative medicine.
Umbilical cord blood contains special stem cells that may unlock the promise of regenerative medicine.
LOCATION CALIFORNIA CLINIC-DOCTORS
Los Angeles:
Los Angeles:
1121 E. Valley Blvd., San Gabriel, CA 91776
Orange County:
15039 Goldenwest St. Huntington Beach, CA 92647
LOCATION LAS VEGAS CLINIC-DOCTORS
Las Vegas:
Las Vegas:
